Figure 1.
Figure 2.
Clinical and pathological characteristics of the patients included in this study
| Variables | Number | Percent | |
|---|---|---|---|
| Gender | Male | 49 | 63.64 |
| Female | 28 | 36.36 | |
| Tumor location | Corpus | 43 | 55.84 |
| Cardia | 14 | 18.18 | |
| Antrum | 9 | 11.69 | |
| Multiple | 6 | 7.79 | |
| Pylorus | 5 | 6.49 | |
| Histological type | Classic | 22 | 28.57 |
| Less cohesive | 21 | 27.27 | |
| Mixed | 20 | 25.97 | |
| Papillary | 6 | 7.79 | |
| Lymphoid stroma | 4 | 5.19 | |
| Tubular | 3 | 3.90 | |
| Mucinous | 1 | 1.30 | |
| Histological grade | Moderately | 38 | 49.35 |
| differentiated | |||
| Poorly differentiated | 33 | 42.86 | |
| Well differentiated | 6 | 7.79 | |
| Tumor budding | Grade 1 | 29 | 37.66 |
| Grade 2 | 17 | 22.08 | |
| Grade 3 | 31 | 40.26 | |
| LVI | Present | 60 | 77.92 |
| Absent | 17 | 22.08 | |
| PNI | Present | 48 | 62.34 |
| Absent | 29 | 37.66 | |
| Lymph mode metastasis | Present | 52 | 67.53 |
| Absent | 25 | 32.47 | |
| Stage | 1A | 7 | 9.09 |
| 1B | 2 | 2.60 | |
| 2A | 13 | 16.88 | |
| 2B | 7 | 9.09 | |
| 3A | 23 | 29.87 | |
| 3B | 8 | 10.39 | |
| 3C | 13 | 16.88 | |
| 4A | 4 | 5.19 | |
| MMR/MSI | Preserved | 59 | 76.62 |
| Lost | 18 | 23.38 | |
| EBV | Negative | 68 | 88.31 |
| Positive | 9 | 11.69 | |
| TSR | Low | 17 | 22.08 |
| High | 60 | 77.92 | |
| Tumor infiltrating and peritumoral lymphocyte presence | Grade 1 | 16 | 20.78 |
| Grade 2 | 17 | 22.08 | |
| Grade 3 | 44 | 57.14 |